Corporate Profile

We are an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, we seek to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. Our OMNI® Surgical System is a safe, minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG), the leading cause of irreversible blindness. Our TearCare® System is 510(k) cleared for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), enabling office-based clearance of gland obstructions by physicians to address the leading cause of dry eye disease.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases